Literature DB >> 350244

Electrophysiological effects of edrophonium in the innervated and the transplanted denervated human heart.

D R Stemple, R J Hall, J W Mason, D C Harrison.   

Abstract

In order to determine the mechanism of action of edrophonium on the cardiac conduction system, we used His bundle recording and pacing techniques to examine the electrophysiological effect of edrophonium in 6 patients undergoing diagnostic evaluation for coronary artery disease and in 9 cardiac transplant recipients who were free of acute graft rejection. After control measures were made of sinus cycle length, conduction intervals, and conduction system refractory periods, edrophonium was administered by constant intravenous infusion, and all electrophysiological measurements were repeated. In the normally innervated patients, edrophonium significantly increased sinus cycle length from 778 +/- 21 ms to 883 +/- 36 ms (P less than 0.01), AH interval from 88 +/- 11 ms to 100 +/- 12 ms (P less than 0.01), and AV nodal functional refractory period from 351 +/- 44 ms to 391 +/- 36 ms (P less than 0.05). In the patients with transplanted hearts, edrophonium had no electrophysiological effect other than increasing the cycle length of the remnant recipient atrium from 722 +/- 21 ms to 798 +/- 31 ms (P less than 0.01). We conclude that the electrophysiological effects of edrophonium in man are mediated primarily through autonomic innervation of the heart.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 350244      PMCID: PMC483462          DOI: 10.1136/hrt.40.6.644

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  13 in total

1.  Supersensitivity of skeletal muscle produced by botulinum toxin.

Authors:  S THESLEFF
Journal:  J Physiol       Date:  1960-06       Impact factor: 5.182

2.  Electrophysiological studies in the denervated transplanted human heart. Response to trial pacing and atropine.

Authors:  D S Cannom; A F Graham; D C Harrison
Journal:  Circ Res       Date:  1973-02       Impact factor: 17.367

Review 3.  Parasympathetic control of the heart.

Authors:  C B Higgins; S F Vatner; E Braunwald
Journal:  Pharmacol Rev       Date:  1973-03       Impact factor: 25.468

4.  Supraventricular tachyarrhythmias. Treatment with edrophonium.

Authors:  J D Cantwell; J E Dawson; G F Fletcher
Journal:  Arch Intern Med       Date:  1972-08

5.  Evaluation of cardiac conduction in the cardiac catheterization laboratory.

Authors:  K M Rosen
Journal:  Am J Cardiol       Date:  1972-11-08       Impact factor: 2.778

6.  Cardiac transplantation in man. 3. Surgical aspects.

Authors:  E B Stinson; E Dong; A B Iben; N E Shumway
Journal:  Am J Surg       Date:  1969-08       Impact factor: 2.565

7.  The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions.

Authors:  B S Kolman; R L Verrier; B Lown
Journal:  Circulation       Date:  1975-10       Impact factor: 29.690

8.  Use of edrophonium (tensilon) in the evaluation of cardiac arrhythmias.

Authors:  R C Reddy; L Gould; R F Gomprecht
Journal:  Am Heart J       Date:  1971-12       Impact factor: 4.749

9.  Continuous infusion of edrophonium (Tensilon) in treating supraventricular arrhythmias.

Authors:  J Frieden; J A Cooper; J I Grossman
Journal:  Am J Cardiol       Date:  1971-03       Impact factor: 2.778

10.  The pharmacokinetics of (14C)-edrophonium in normal wistar rats and homozygous Gunn rats with ligated renal pedicles.

Authors:  D J Back; T N Calvey
Journal:  Br J Pharmacol       Date:  1974-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.